TransMedics Group (TMDX) Tops Q4 EPS by 19c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts TMDX Hot Sheet
Join SI Premium – FREE
TransMedics Group (NASDAQ: TMDX) reported Q4 EPS of $0.12, $0.19 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $81.2 million versus the consensus estimate of $68.49 million.
GUIDANCE:
TransMedics Group sees FY2024 revenue of $360-370 million, versus the consensus of $330.2 million.
For earnings history and earnings-related data on TransMedics Group (TMDX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Downgrades Norsk Hydro SA (NHY:NO) (NHYDY) to Neutral
- Goldman Sachs sees US stocks dip on tech earnings and macro shifts
- Meta's capital-raising plans expose a major weakness in the AI boom
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
